Clyde E. Markowitz, MD

Miller TM, Cudkowicz ME, Shaw PJ, Genge A, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Salachas F, Bruneteau G, Al-Chalabi A, Amorin M, Nestorov I, Graham D, Lin L, Sun P, McNeill M, Malek S, Inra J, Garafalo S, Fradette S; VALOR and OLE Working Group. Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis , JAMA Neurol, 83: 2026,115-125

Simon Thebault, Samantha Soldan, Gautier Breville, Luana Yamashita, Elia Afanasiev, jo Anne stratton, Christopher Perrone, Clyde Markowitz, Paul Lieberman, Amit Bar-Or "Immunophenotypic characterisation of EBV-infected B cells in MS blood and CSF using PrimeFlow" , ECTRIMS 2025, Barcelona , Spain , 31(3): 2025

Naydovich LR, Orthmann-Murphy JL, Markowitz CE. Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment , Neurotherapeutics, 22 (4): 2025

Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur R, Jacobs DA, Markowitz C, Moore T, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB. Investigating mood and cognition in people with multiple sclerosis: a prospective cross-sectional study protocol , BMJ Open, 15: 2025,e094733

Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT. Impact of insurance status on MRI phenotypes in MS , Mult Scler Relat Disord: 2024

Baller EB, Sweeney EM, Cieslak M, Robert-Fitzgerald T, Covitz SC, Martin ML, Schindler MK, Bar-Or A, Elahi A, Larsen BS, Manning AR, Markowitz CE, Perrone CM, Rautman V, Seitz MM, Detre JA, Fox MD, Shinohara RT, Satterthwaite TD. Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis , Biol Psychiatry, 95: 2024,1072-1080

Coyle PK, Freedman MS, Cohen BA, Cree BAC, Markowitz CE. Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review , Ann Clin Transl Neurol, 11(4): 2024,842-855

Gandelman S, Lenzi KA, Markowitz C, Berger JR. A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy , Neurol Clin Pract, 14(1): 2024

Clark KA, O'Donnell CM, Elliott MA, Tauhid S, Dewey BE, Chu R, Khalil S, Nair G, Sati P, DuVal A, Pellegrini N, Bar-Or A, Markowitz C, Schindler MK, Zurawski J, Calabresi PA, Reich DS, Bakshi R, Shinohara RT; NAIMS Cooperative. Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis , J Neuroimaging, 33(6): 2023,941–952

Thebault S, Gandelman S, Lane C, Kim EJ, Pileggi C, Zuroff L, Yamashita LD, Schindler MK, Chiu C, Wilson MR, Berger JR, Markowitz C, Bar-Or A, Fuller R, Brandstadter R, Pruitt AA, Jacobs DA. Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis , Neurol Neuroimmunol Neuroinflamm, 10: 2023,e200154